Skip to main content

J1596 HCPCS Level II Code: Injection, glycopyrrolate, 0.1 mg

Medicare Coverage & Payment

  • CMS short descriptor: Inj, glycopyrrolate, 0.1 mg
  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: January 1, 2025

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Code Overview

Injection, glycopyrrolate, 0.1 mg is a HCPCS Level II code (J1596). CMS assigns coverage code C — Carrier judgment. Short description: Inj, glycopyrrolate, 0.1 mg.

Summary composed by MedCoder from this code's official HCPCS Level II record. The tabular instructional notes themselves appear verbatim below.

Change history

  • 2024-01-01
    Added to the code set
    Injection, glycopyrrolate, 0.1 mg

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $0.36

00143-9584-10 Glycopyrrolate Injection — Hikma Pharmaceuticals USA Inc. (size 20 × qty 10 (0.1 MG per billing unit))

00143-9585-25 Glycopyrrolate Injection — Hikma Pharmaceuticals USA Inc. (size 5 × qty 25 (0.1 MG per billing unit))

00143-9586-25 Glycopyrrolate Injection — Hikma Pharmaceuticals USA Inc. (size 2 × qty 25 (0.1 MG per billing unit))

00143-9587-25 Glycopyrrolate Injection — Hikma Pharmaceuticals USA Inc. (size 1 × qty 25 (0.1 MG per billing unit))

00143-9679-10 Glycopyrrolate Injection — Hikma Pharmaceuticals USA Inc. (size 20 × qty 10 (0.1 MG per billing unit))

00143-9680-25 Glycopyrrolate Injection — Hikma Pharmaceuticals USA Inc. (size 5 × qty 25 (0.1 MG per billing unit))

00143-9681-25 Glycopyrrolate Injection — Hikma Pharmaceuticals USA Inc. (size 2 × qty 25 (0.1 MG per billing unit))

00143-9682-25 Glycopyrrolate Injection — Hikma Pharmaceuticals USA Inc. (size 1 × qty 25 (0.1 MG per billing unit))

00404-9775-01 Glycopyrrolate Injection — Henry Schein Inc. (size 1 × qty 1 (0.1 MG per billing unit))

00404-9776-05 Glycopyrrolate Injection — Henry Schein Inc. (size 5 × qty 1 (0.1 MG per billing unit))

00404-9777-20 Glycopyrrolate Injection — Henry Schein Inc. (size 20 × qty 1 (0.1 MG per billing unit))

00404-9782-02 Glycopyrrolate Injection — Henry Schein Inc. (size 2 × qty 1 (0.1 MG per billing unit))

00404-9867-01 Glycopyrrolate Injection — Henry Schein Inc. (size 1 × qty 1 (0.1 MG per billing unit))

00404-9868-20 Glycopyrrolate Injection — Henry Schein Inc. (size 20 × qty 1 (0.1 MG per billing unit))

00404-9869-02 Glycopyrrolate Injection — Henry Schein Inc. (size 2 × qty 1 (0.1 MG per billing unit))

00404-9870-05 Glycopyrrolate Injection — Henry Schein Inc. (size 5 × qty 1 (0.1 MG per billing unit))

00517-4601-25 Glycopyrrolate Injection — American Regent, Inc. (size 1 × qty 25 (0.1 MG per billing unit))

00517-4602-25 Glycopyrrolate Injection — American Regent, Inc. (size 2 × qty 25 (0.1 MG per billing unit))

00517-4605-25 Glycopyrrolate Injection — American Regent, Inc. (size 5 × qty 25 (0.1 MG per billing unit))

00517-4620-25 Glycopyrrolate Injection — American Regent, Inc. (size 20 × qty 25 (0.1 MG per billing unit))

+67 more

Related Codes

Same drug, other billing codes

CMS's ASP crosswalk lists these HCPCS codes for the same drug.

J1598 — Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J1596 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (29)

  • J1551 — Injection, immune globulin (cutaquig), 100 mg [Sibling]
  • J1552 — Injection, immune globulin (alyglo), 500 mg [Sibling]
  • J1553 — Injection, immune globulin (yimmugo), 100 mg [Sibling]
  • J1554 — Injection, immune globulin (asceniv), 500 mg [Sibling]
  • J1555 — Injection, immune globulin (cuvitru), 100 mg [Sibling]
  • J1556 — Injection, immune globulin (bivigam), 500 mg [Sibling]
  • J1557 — Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg [Sibling]
  • J1558 — Injection, immune globulin (xembify), 100 mg [Sibling]
  • and 21 more

Change history

  • 2024-01-01 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J1596 in its code family, with their registry titles.

  • J1574 — Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
  • J1575 — Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
  • J1576 — Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
  • J1577 — Injection, immune globulin (qivigy), 100 mg
  • J1580 — Injection, garamycin, gentamicin, up to 80 mg
  • J1590 — Injection, gatifloxacin, 10 mg
  • J1595 — Injection, glatiramer acetate, 20 mg
  • J1597 — Injection, glycopyrrolate (glyrx-pf), 0.1 mg
  • J1598 — Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
  • J1599 — Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg